U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Grade 2 Dry Skin, CTCAE

MedGen UID:
282011
•Concept ID:
C1559111
•
Finding

Definition

Covering 10-30% BSA and associated with erythema or pruritus; limiting instrumental ADL [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVGrade 2 Dry Skin, CTCAE

Professional guidelines

PubMed

Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
Ocvirk J, Cencelj S
J Eur Acad Dermatol Venereol 2010 Apr;24(4):453-9. Epub 2009 Sep 27 doi: 10.1111/j.1468-3083.2009.03446.x. PMID: 19793151

Recent clinical studies

Etiology

Implementation of 26 Gy in five fractions over 1 week adjuvant radiotherapy for breast cancer: Prospective report of acute skin toxicity and consideration of resource implications.
Nugent K, Quinlan E, Cleary S, O'Driscoll H, Rohan C, Trousdell J, Williams J, Dunne M, McArdle O, Duane FK
Breast 2023 Feb;67:55-61. Epub 2022 Dec 16 doi: 10.1016/j.breast.2022.12.008. PMID: 36603414Free PMC Article
Monoclonal antibody-induced papulopustular rash: Clinical course, communication to health-care professionals and reactive measures as reported by patients.
Cignola S, Gonella S, Alessandra B, Palese A
Eur J Oncol Nurs 2016 Feb;20:133-9. Epub 2015 Jul 15 doi: 10.1016/j.ejon.2015.07.003. PMID: 26187661

Therapy

Implementation of 26 Gy in five fractions over 1 week adjuvant radiotherapy for breast cancer: Prospective report of acute skin toxicity and consideration of resource implications.
Nugent K, Quinlan E, Cleary S, O'Driscoll H, Rohan C, Trousdell J, Williams J, Dunne M, McArdle O, Duane FK
Breast 2023 Feb;67:55-61. Epub 2022 Dec 16 doi: 10.1016/j.breast.2022.12.008. PMID: 36603414Free PMC Article
Monoclonal antibody-induced papulopustular rash: Clinical course, communication to health-care professionals and reactive measures as reported by patients.
Cignola S, Gonella S, Alessandra B, Palese A
Eur J Oncol Nurs 2016 Feb;20:133-9. Epub 2015 Jul 15 doi: 10.1016/j.ejon.2015.07.003. PMID: 26187661
Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
Ocvirk J, Cencelj S
J Eur Acad Dermatol Venereol 2010 Apr;24(4):453-9. Epub 2009 Sep 27 doi: 10.1111/j.1468-3083.2009.03446.x. PMID: 19793151

Prognosis

Monoclonal antibody-induced papulopustular rash: Clinical course, communication to health-care professionals and reactive measures as reported by patients.
Cignola S, Gonella S, Alessandra B, Palese A
Eur J Oncol Nurs 2016 Feb;20:133-9. Epub 2015 Jul 15 doi: 10.1016/j.ejon.2015.07.003. PMID: 26187661

Clinical prediction guides

Monoclonal antibody-induced papulopustular rash: Clinical course, communication to health-care professionals and reactive measures as reported by patients.
Cignola S, Gonella S, Alessandra B, Palese A
Eur J Oncol Nurs 2016 Feb;20:133-9. Epub 2015 Jul 15 doi: 10.1016/j.ejon.2015.07.003. PMID: 26187661
Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer.
Ocvirk J, Cencelj S
J Eur Acad Dermatol Venereol 2010 Apr;24(4):453-9. Epub 2009 Sep 27 doi: 10.1111/j.1468-3083.2009.03446.x. PMID: 19793151

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...